Abstract: Received: 18 May 2020 | | Revised: 24 June 2020 Accepted: 25 June 2020 DOI: 10.1111/ajt.16185 B R I E F C O M M U N I C AT I O N COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium Paolo Cravedi1 | Suraj S. Mothi2 | Yorg Azzi3 | Meredith Haverly1 | Samira S. Farouk4 | 5 5 1 4 María J. Pérez-Sáez | Maria D. Redondo-Pachón | Barbara Murphy | Sander Florman | 2 Laura G. Cyrino | Monica Grafals6 | Sandheep Venkataraman6 | Xingxing S. Cheng7 | 7 8 9 10 Aileen X. Wang | Gianluigi Zaza | Andrea Ranghino | Lucrezia Furian | 11 Joaquin Manrique | Umberto Maggiore12 | Ilaria Gandolfini12 | Nikhil Agrawal13 | | Leonardo V. Riella14,15 Het Patel13 | Enver Akalin3 1 Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York 2 Schuster Transplantation Research Center, Brigham & Women’s Hospital, Harvard Medical School, Boston, Massachusetts 3 Division of Nephrology, Montefiore Medical Center Transplant Center, Albert Einstein College of Medicine, Bronx, New York 4 Recanati-Miller Transplantation Institute, Mount Sinai Hospital, New York, New York 5 Servicio de Nefrología, Hospital del Mar, Barcelona, Spain 6 Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado 7 Department of Medicine, Division of Nephrology, Stanford University School of Medicine, Stanford, Massachusetts 8 Renal Unit, Department of Medicine, University Hospital of Verona, Verona, Italy 9 SOD Nefrologia, Dialisi e Trapianto Rene, AOU Ospedali Riuniti, Ancona, Italy 10 Kidney and Pancreas Transplantation Unit, Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Padova, Italy 11 Nephrology Service, Complejo Hospitalario de Navarra, Pamplona, Spain 12 Dipartimento di Medicina e Chirurgia, Università di Parma, UO Nefrologia, Azienda Ospedaliera-Universitaria Parma, Parma, Italy 13 Division of Nephrology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 14 Division of Nephrology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 15 Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts Correspondence Paolo Cravedi Email: paolo.cravedi@mssm.edu Leonardo V. Riella Email: lriella@mgh.harvard.edu Kidney transplant recipients may be at a high risk of developing critical coronavirus disease 2019 (COVID-19) illness due to chronic immunosuppression and comorbidities. We identified hospitalized adult kidney transplant recipients at 12 transplant centers in the United States, Italy, and Spain who tested positive for COVID-19. Clinical presentation, laboratory values, immunosuppression, and treatment strategies were reviewed, and predictors of poor clinical outcomes were determined through multivariable analyses. Among 9845 kidney transplant recipients across centers, 144 were hospitalized due to COVID-19 during the 9-week study period. Of the 144 patients, 66% were male with a mean age of 60 (±12) years, and 40% were Hispanic and 25% Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; CNI, calcineurin inhibitor; COVID-19, coronavirus disease 2019; IL, interleukin; MMF, mycophenolate mofetil; SARS-CoV-2, severe acute respiratory syndrome coronavirus-2. Enver Akalin and Leonardo V. Riella are co-senior authors. Paolo Cravedi and Suraj Sarvode Mothi..